Translation of Enhanced Bioavailability of a Nano-Micellar Curcumin Formulation (Biowell Lytox+) into Improved Clinical Outcomes in Acne-Prone Skin: A Pharmacokinetic and Exploratory Clinical Study
MEDS Basic Medicine · 2026 · 4 (1)
DOI: 10.23977/medbm.2026.040106 ↗Kurz gefasst
Fachartikel in der Zeitschrift MEDS Basic Medicine, 2026.
Abstract (Originalsprache)
: This study evaluated the pharmacokinetic profile of a nano-micellar liquid curcumin formulation (Biowell Lytox+) and its clinical effects on acne-prone skin through a single-dose crossover pharmacokinetic trial and a 12-week clinical evaluation. Pharmacokinetic results showed that, compared with native curcumin powder, the nano-micellar formulation achieved a 193-fold increase in relative bioavailability (p
Zitieren
APA
(2026). Translation of Enhanced Bioavailability of a Nano-Micellar Curcumin Formulation (Biowell Lytox+) into Improved Clinical Outcomes in Acne-Prone Skin: A Pharmacokinetic and Exploratory Clinical Study. MEDS Basic Medicine, 4(1). https://doi.org/10.23977/medbm.2026.040106
Vancouver
Translation of Enhanced Bioavailability of a Nano-Micellar Curcumin Formulation (Biowell Lytox+) into Improved Clinical Outcomes in Acne-Prone Skin: A Pharmacokinetic and Exploratory Clinical Study. MEDS Basic Medicine. 2026;4(1). doi:10.23977/medbm.2026.040106
BibTeX
@article{euvimed2026,
title = {Translation of Enhanced Bioavailability of a Nano-Micellar Curcumin Formulation (Biowell Lytox+) into Improved Clinical Outcomes in Acne-Prone Skin: A Pharmacokinetic and Exploratory Clinical Study},
journal = {MEDS Basic Medicine},
year = {2026},
volume = {4},
number = {1},
doi = {10.23977/medbm.2026.040106}
}
EUVIMED